Igor Bondarenko
Researcher Next ID · RN-013660
Researcher · Medicine
Dnipro State Medical University
, Ukraine
- Works count
- 630
- Citation count
- 56,170
- H-index
- 83
- i10-index
- 214
Research interests
Publications
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2019 · 10.1056/nejmoa1816714
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(19)32222-6
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
New England Journal of Medicine · 2011 · 10.1056/nejmoa1104621
Current projects
No projects listed.